Ciclesonide - PDFSEARCH.IO - Document Search Engine

Ciclesonide
Results: 38

#	Item
11	Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Add to Reading List Source URL: www.kdheks.gov Language: English - Date: 2013-11-27 12:12:20 Organic chemistry Ciclesonide Corticosteroid Mometasone furoate Budesonide Medicaid Fluticasone propionate Glucocorticoids Pulmonology Chemistry
12	Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Add to Reading List Source URL: www.kdheks.gov Language: English - Date: 2014-06-30 15:07:52 Budesonide Ciclesonide Mometasone furoate Medicaid Corticosteroid Glucocorticoids Chemistry Organic chemistry
13	Global Strategy for Asthma Management and Prevention[removed]update) Publications Reviewed by the GINA Science Committee The process to produce this 2009 update included a Pub Med search using search fields established by Add to Reading List Source URL: www.ginasthma.org Language: English Respiratory therapy Asthma Ketones Ciclesonide Formoterol Allergy Omalizumab Bronchial thermoplasty Salmeterol Medicine Pulmonology Chemistry
14	Summary Basis of Decision Alvesco Add to Reading List Source URL: hc-sc.gc.ca Language: English - Date: 2013-07-12 14:26:36 Pharmacology Alcohols Chemistry Ciclesonide Glucocorticoids Ketones Metered-dose inhaler Inhaler Asthma Dosage forms Medicine
15	October[removed]Publications reviewed for Global Strategy for the Asthma Management and Prevention (GINA Workshop Report) - Updated 2005 The manuscripts listed below were chosen according to the methodology described by th Add to Reading List Source URL: www.ginasthma.org Language: English Glucocorticoids Asthma Phenols Alcohols Formoterol Ciclesonide Fluticasone propionate Budesonide/formoterol Salmeterol Pulmonology Medicine Respiratory therapy
16	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALVESCO® safely and effectively. See full prescribing information for ALVESCO®. ALVESCO® (ciclesonide) Inhalation Add to Reading List Source URL: www.fda.gov Language: English Medicine Ciclesonide Glucocorticoids Ketones Autoimmune diseases Piperazines Asthma Corticosteroid Eczema Chemistry Organic chemistry Alcohols
17	November 10, 2003 Citations Reviewed by GINA Science Committee Global Strategy for Asthma Diagnosis and Management Updated[removed]. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood As Add to Reading List Source URL: www.ginasthma.org Language: English Asthma Glucocorticoids Combination drugs Phenols Formoterol Salmeterol Ciclesonide Budesonide/formoterol Fluticasone/salmeterol Pulmonology Medicine Respiratory therapy
18	Publications reviewed for GINA Workshop Report: Update 2004 Publication Date from[removed]to[removed]. Agertoft L, Laulund LW, Harrison LI, Pedersen S. Influence of particle size on lung deposition and pharmacoki Add to Reading List Source URL: www.ginasthma.org Language: English Respiratory therapy Phenols Alcohols Glucocorticoids Phenethylamines Asthma Formoterol Cromoglicic acid Ciclesonide Chemistry Pulmonology Organic chemistry
19	REFERENCES REVIEWED FOR 2007 GINA UPDATE Selected from PUB MED for the period July 1, 2006 through June 30, 2007 Criteria: Asthma, All Fields, items with abstracts, human, clinical trial and Asthma AND systematic, All F Add to Reading List Source URL: www.ginasthma.org Language: English Asthma Respiratory therapy Allergology Respiratory diseases Immunology Ciclesonide Allergy Bronchial thermoplasty Formoterol Medicine Health Pulmonology
20	REFERENCES REVIEWED FOR 2007 GINA UPDATE Selected from PUB MED for the period July 1, 2006 through June 30, 2007 Criteria: Asthma, All Fields, items with abstracts, human, clinical trial and Asthma AND systematic, All F Add to Reading List Source URL: www.ginasthma.org Language: English Asthma Respiratory therapy Allergology Respiratory diseases Immunology Ciclesonide Allergy Bronchial thermoplasty Formoterol Medicine Health Pulmonology

UPDATE